TAU technology offers single-injection treatment for HIV infection
A new study from Tel Aviv University (TAU) offers a new and unique treatment for AIDS which may be developed into a vaccine or a one-time treatment for patients with HIV. The study examined the engineering of type B white blood cells in the patient’s body to secrete anti-HIV antibodies in response to the virus…. Read More